Latest Breaking News On - Aligo quarterly report - Page 1 : comparemela.com

Aligos Therapeutics Announces Six Abstracts Accepted for Presentation at EASL 2024

Aligos Therapeutics Announces Six Abstracts Accepted for Presentation at EASL 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomJordyn taraziJin hongKosh agarwalFung yuenMichael fitzhughYannick debingKha leLifesci communicationsDivision of gastroenterologyAligos therapeutics incUniversity of hong kongExchange commissionInvestor relations corporate communicationsExchange commission on

Aligos Therapeutics to Announce 1st Quarter 2024 Financial Results on May 7, 2024

Aligos Therapeutics to Announce 1st Quarter 2024 Financial Results on May 7, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Jordyn taraziMichael fitzhughInvestor relations corporate communicationsLifesci communicationsExchange commissionAligos therapeutics incExchange commission onSecurities litigation reform actAligo quarterly reportInvestor relations

Aligos Therapeutics to Announce 1st Quarter 2024 Financial Results on May 7, 2024

Aligos Therapeutics to Announce 1st Quarter 2024 Financial Results on May 7, 2024
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Michael fitzhughJordyn taraziExchange commissionLifesci communicationsExchange commission onAligos therapeutics incInvestor relations corporate communicationsAligos therapeuticsSecurities litigation reform actAligo quarterly reportInvestor relations

Aligos Therapeutics Mourns the Passing of MASH Industry Leader Stephen A Harrison, MD

SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical

Jordyn taraziLawrence blattMichael fitzhughStephena harrisonLifesci communicationsExchange commission onPrincipal investigator for the companyAligos therapeutics incExchange commissionInvestor relations corporate communicationsPrincipal investigatorChief executive officerSecurities litigation reform actAligo quarterly reportInvestor relationsAssociated press

Aligos Therapeutics Mourns the Passing of MASH Industry Leader Stephen A Harrison, MD

SOUTH SAN FRANCISCO, Calif., April 25, 2024 Aligos Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in.

Lawrence blattJordyn taraziStephena harrisonMichael fitzhughExchange commissionAligos therapeutics incLifesci communicationsPrincipal investigator for the companyInvestor relations corporate communicationsExchange commission onPrincipal investigatorChief executive officerSecurities litigation reform actAligo quarterly reportInvestor relations